![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PIP5K1A |
Gene summary for PIP5K1A |
![]() |
Gene information | Species | Human | Gene symbol | PIP5K1A | Gene ID | 8394 |
Gene name | phosphatidylinositol-4-phosphate 5-kinase type 1 alpha | |
Gene Alias | PIP5K1A | |
Cytomap | 1q21.3 | |
Gene Type | protein-coding | GO ID | GO:0001667 | UniProtAcc | Q99755 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
8394 | PIP5K1A | P56T-E | Human | Esophagus | ESCC | 5.14e-10 | 7.12e-01 | 0.1613 |
8394 | PIP5K1A | P57T-E | Human | Esophagus | ESCC | 3.25e-24 | 1.87e-01 | 0.0926 |
8394 | PIP5K1A | P61T-E | Human | Esophagus | ESCC | 2.64e-17 | 3.16e-01 | 0.099 |
8394 | PIP5K1A | P62T-E | Human | Esophagus | ESCC | 7.85e-36 | 6.44e-01 | 0.1302 |
8394 | PIP5K1A | P65T-E | Human | Esophagus | ESCC | 8.27e-28 | 1.83e-01 | 0.0978 |
8394 | PIP5K1A | P74T-E | Human | Esophagus | ESCC | 1.15e-16 | 5.47e-01 | 0.1479 |
8394 | PIP5K1A | P75T-E | Human | Esophagus | ESCC | 1.94e-29 | 7.74e-01 | 0.1125 |
8394 | PIP5K1A | P76T-E | Human | Esophagus | ESCC | 7.44e-18 | 2.33e-01 | 0.1207 |
8394 | PIP5K1A | P79T-E | Human | Esophagus | ESCC | 1.55e-08 | 1.81e-01 | 0.1154 |
8394 | PIP5K1A | P80T-E | Human | Esophagus | ESCC | 4.27e-24 | 7.76e-01 | 0.155 |
8394 | PIP5K1A | P82T-E | Human | Esophagus | ESCC | 2.38e-11 | 5.50e-01 | 0.1072 |
8394 | PIP5K1A | P83T-E | Human | Esophagus | ESCC | 2.11e-16 | 2.22e-01 | 0.1738 |
8394 | PIP5K1A | P84T-E | Human | Esophagus | ESCC | 3.64e-07 | 4.92e-01 | 0.0933 |
8394 | PIP5K1A | P89T-E | Human | Esophagus | ESCC | 4.41e-05 | 5.64e-01 | 0.1752 |
8394 | PIP5K1A | P91T-E | Human | Esophagus | ESCC | 1.42e-03 | 7.39e-01 | 0.1828 |
8394 | PIP5K1A | P107T-E | Human | Esophagus | ESCC | 3.79e-27 | 7.76e-01 | 0.171 |
8394 | PIP5K1A | P126T-E | Human | Esophagus | ESCC | 1.22e-02 | 7.95e-01 | 0.1125 |
8394 | PIP5K1A | P127T-E | Human | Esophagus | ESCC | 6.21e-30 | 7.27e-01 | 0.0826 |
8394 | PIP5K1A | P128T-E | Human | Esophagus | ESCC | 1.20e-21 | 9.09e-01 | 0.1241 |
8394 | PIP5K1A | P130T-E | Human | Esophagus | ESCC | 4.04e-42 | 1.17e+00 | 0.1676 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00315898 | Cervix | CC | cell-substrate adhesion | 96/2311 | 363/18723 | 1.48e-13 | 8.85e-11 | 96 |
GO:00016679 | Cervix | CC | ameboidal-type cell migration | 110/2311 | 475/18723 | 2.66e-11 | 6.36e-09 | 110 |
GO:00085446 | Cervix | CC | epidermis development | 83/2311 | 324/18723 | 3.91e-11 | 8.54e-09 | 83 |
GO:00435884 | Cervix | CC | skin development | 71/2311 | 263/18723 | 8.04e-11 | 1.46e-08 | 71 |
GO:01501159 | Cervix | CC | cell-substrate junction organization | 37/2311 | 101/18723 | 3.20e-10 | 4.46e-08 | 37 |
GO:007265910 | Cervix | CC | protein localization to plasma membrane | 73/2311 | 284/18723 | 4.95e-10 | 6.73e-08 | 73 |
GO:00070448 | Cervix | CC | cell-substrate junction assembly | 34/2311 | 95/18723 | 3.35e-09 | 3.45e-07 | 34 |
GO:19907788 | Cervix | CC | protein localization to cell periphery | 78/2311 | 333/18723 | 1.22e-08 | 9.73e-07 | 78 |
GO:00071608 | Cervix | CC | cell-matrix adhesion | 60/2311 | 233/18723 | 1.58e-08 | 1.23e-06 | 60 |
GO:00302164 | Cervix | CC | keratinocyte differentiation | 42/2311 | 139/18723 | 1.74e-08 | 1.28e-06 | 42 |
GO:00603267 | Cervix | CC | cell chemotaxis | 73/2311 | 310/18723 | 2.82e-08 | 1.96e-06 | 73 |
GO:00430877 | Cervix | CC | regulation of GTPase activity | 79/2311 | 348/18723 | 4.21e-08 | 2.60e-06 | 79 |
GO:00099137 | Cervix | CC | epidermal cell differentiation | 53/2311 | 202/18723 | 5.48e-08 | 3.25e-06 | 53 |
GO:00343298 | Cervix | CC | cell junction assembly | 88/2311 | 420/18723 | 3.42e-07 | 1.38e-05 | 88 |
GO:00480417 | Cervix | CC | focal adhesion assembly | 28/2311 | 87/18723 | 9.86e-07 | 3.45e-05 | 28 |
GO:00315328 | Cervix | CC | actin cytoskeleton reorganization | 31/2311 | 107/18723 | 3.34e-06 | 8.99e-05 | 31 |
GO:00435476 | Cervix | CC | positive regulation of GTPase activity | 53/2311 | 255/18723 | 8.72e-05 | 1.16e-03 | 53 |
GO:00107615 | Cervix | CC | fibroblast migration | 13/2311 | 47/18723 | 3.62e-03 | 2.31e-02 | 13 |
GO:0006909 | Cervix | CC | phagocytosis | 53/2311 | 308/18723 | 7.49e-03 | 4.01e-02 | 53 |
GO:0014065 | Cervix | CC | phosphatidylinositol 3-kinase signaling | 28/2311 | 144/18723 | 9.50e-03 | 4.72e-02 | 28 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0451010 | Cervix | CC | Focal adhesion | 59/1267 | 203/8465 | 1.53e-07 | 1.84e-06 | 1.09e-06 | 59 |
hsa0481016 | Cervix | CC | Regulation of actin cytoskeleton | 64/1267 | 229/8465 | 2.24e-07 | 2.59e-06 | 1.53e-06 | 64 |
hsa0414418 | Cervix | CC | Endocytosis | 64/1267 | 251/8465 | 6.97e-06 | 6.10e-05 | 3.61e-05 | 64 |
hsa0466612 | Cervix | CC | Fc gamma R-mediated phagocytosis | 31/1267 | 97/8465 | 1.78e-05 | 1.42e-04 | 8.40e-05 | 31 |
hsa0513516 | Cervix | CC | Yersinia infection | 39/1267 | 137/8465 | 3.27e-05 | 2.41e-04 | 1.42e-04 | 39 |
hsa0451014 | Cervix | CC | Focal adhesion | 59/1267 | 203/8465 | 1.53e-07 | 1.84e-06 | 1.09e-06 | 59 |
hsa0481017 | Cervix | CC | Regulation of actin cytoskeleton | 64/1267 | 229/8465 | 2.24e-07 | 2.59e-06 | 1.53e-06 | 64 |
hsa0414419 | Cervix | CC | Endocytosis | 64/1267 | 251/8465 | 6.97e-06 | 6.10e-05 | 3.61e-05 | 64 |
hsa0466613 | Cervix | CC | Fc gamma R-mediated phagocytosis | 31/1267 | 97/8465 | 1.78e-05 | 1.42e-04 | 8.40e-05 | 31 |
hsa0513517 | Cervix | CC | Yersinia infection | 39/1267 | 137/8465 | 3.27e-05 | 2.41e-04 | 1.42e-04 | 39 |
hsa0451015 | Endometrium | AEH | Focal adhesion | 58/1197 | 203/8465 | 4.99e-08 | 7.37e-07 | 5.39e-07 | 58 |
hsa0414420 | Endometrium | AEH | Endocytosis | 56/1197 | 251/8465 | 2.58e-04 | 2.15e-03 | 1.57e-03 | 56 |
hsa0466614 | Endometrium | AEH | Fc gamma R-mediated phagocytosis | 27/1197 | 97/8465 | 3.02e-04 | 2.39e-03 | 1.75e-03 | 27 |
hsa0481018 | Endometrium | AEH | Regulation of actin cytoskeleton | 50/1197 | 229/8465 | 9.08e-04 | 5.78e-03 | 4.23e-03 | 50 |
hsa0451016 | Endometrium | AEH | Focal adhesion | 58/1197 | 203/8465 | 4.99e-08 | 7.37e-07 | 5.39e-07 | 58 |
hsa04144110 | Endometrium | AEH | Endocytosis | 56/1197 | 251/8465 | 2.58e-04 | 2.15e-03 | 1.57e-03 | 56 |
hsa0466615 | Endometrium | AEH | Fc gamma R-mediated phagocytosis | 27/1197 | 97/8465 | 3.02e-04 | 2.39e-03 | 1.75e-03 | 27 |
hsa0481019 | Endometrium | AEH | Regulation of actin cytoskeleton | 50/1197 | 229/8465 | 9.08e-04 | 5.78e-03 | 4.23e-03 | 50 |
hsa0451024 | Endometrium | EEC | Focal adhesion | 58/1237 | 203/8465 | 1.61e-07 | 2.30e-06 | 1.71e-06 | 58 |
hsa0414424 | Endometrium | EEC | Endocytosis | 57/1237 | 251/8465 | 3.34e-04 | 2.82e-03 | 2.10e-03 | 57 |
Page: 1 2 3 4 5 6 7 8 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PIP5K1A | SNV | Missense_Mutation | c.83C>T | p.Ser28Leu | p.S28L | Q99755 | protein_coding | deleterious_low_confidence(0.01) | benign(0.011) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
PIP5K1A | SNV | Missense_Mutation | novel | c.680N>G | p.Tyr227Cys | p.Y227C | Q99755 | protein_coding | deleterious(0) | possibly_damaging(0.745) | TCGA-AO-A0JC-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | fluorouracil | SD |
PIP5K1A | SNV | Missense_Mutation | c.1673C>T | p.Ser558Leu | p.S558L | Q99755 | protein_coding | deleterious_low_confidence(0) | benign(0) | TCGA-BH-A209-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
PIP5K1A | SNV | Missense_Mutation | rs763944215 | c.1390C>T | p.Arg464Trp | p.R464W | Q99755 | protein_coding | deleterious(0.01) | benign(0.049) | TCGA-C8-A26Y-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PIP5K1A | SNV | Missense_Mutation | c.1163N>T | p.Ala388Val | p.A388V | Q99755 | protein_coding | deleterious(0.01) | possibly_damaging(0.641) | TCGA-D8-A27G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
PIP5K1A | SNV | Missense_Mutation | novel | c.118G>A | p.Glu40Lys | p.E40K | Q99755 | protein_coding | deleterious_low_confidence(0.02) | benign(0.05) | TCGA-PE-A5DE-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | CR |
PIP5K1A | insertion | In_Frame_Ins | novel | c.594_595insCAG | p.His198_Lys199insGln | p.H198_K199insQ | Q99755 | protein_coding | TCGA-E9-A243-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | PD | ||
PIP5K1A | insertion | Frame_Shift_Ins | novel | c.596_597insGGGGCAGGGGGAGCATGATGGAGACAAGATCGTGGGAC | p.Glu200GlyfsTer27 | p.E200Gfs*27 | Q99755 | protein_coding | TCGA-E9-A243-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | PD | ||
PIP5K1A | deletion | Frame_Shift_Del | novel | c.1260delA | p.Ala421ProfsTer35 | p.A421Pfs*35 | Q99755 | protein_coding | TCGA-EW-A2FV-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD | ||
PIP5K1A | SNV | Missense_Mutation | novel | c.835C>T | p.Pro279Ser | p.P279S | Q99755 | protein_coding | deleterious(0) | possibly_damaging(0.766) | TCGA-GH-A9DA-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
8394 | PIP5K1A | KINASE, DRUGGABLE GENOME, ENZYME | inhibitor | 252166654 |
Page: 1 |